Johns Hopkins study finds significant improvements in symptom burden and quality of life lasting up to six months after treatment when combining the psychedelic drug with psychological support. This story first appeared on leafie, view here Author: Kevin Dinneen
Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution in women with endometriosis-associated pain. The milestone marks a [...]
When most people think of luxury goods, they picture high-quality, high-priced products. But what truly sets luxury apart is not just cost. It is craftsmanship, design, heritage, cultural cachet, and mastery of materials and technique. Luxury is a sensory experience rooted in both tradition and innovation. [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.